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AbstrACt
Introduction Musculoskeletal deformities and gait 
deviations are common features in ambulatory cerebral palsy 
(CP). Deformity correction through lower limb orthopaedic 
surgery is the standard form of care aimed at improving or 
preserving motor function. Current research on CP care does 
not always take into account individual patients’ expectations 
and needs. There is a wide range of outcome domains and 
outcome measures used to assess outcome from treatment. 
This can lead to reporting bias and make it difficult to 
compare and contrast studies. A core outcome set (COS) 
would enhance the efficiency, relevance and overall quality 
of CP orthopaedic surgery research. The aim of this study is 
to establish a standardised COS for use in evaluating lower 
limb orthopaedic surgery for ambulatory children and young 
people with CP.
Methods/analysis A set of outcomes domains and outcome 
measures will be developed as follows: (1) a qualitative 
evidence synthesis to identify relevant outcomes from 
children and young people and family perspective; (2) a 
scoping review to identify relevant outcomes and outcome 
measures; (3) qualitative research to explore the experience 
of key stakeholders; (4) prioritisation of outcome domains 
will be achieved through a two- round Delphi process with 
key stakeholders; (5) a final COS will be developed at a 
consensus meeting with representation from key stakeholder 
groups.
Ethics and dissemination Ethical approval for this study 
was granted in the UK by the Oxfordshire Research Ethics 
Committee B (REC reference 19/SC/0357). Informed 
consent will be obtained from participants taking part in the 
qualitative research and Delphi process. Study findings will 
be published in an open access journal and presented at 
relevant national and international conferences. Charities and 
associations will be engaged to promote awareness of the 
project COS results.
trial registration number COMET registration: 1236.
PrOsPErO registration number CRD42018089538.
IntrOduCtIOn
Cerebral palsy (CP) is the most common cause 
of childhood physical disability, affecting two 
to three individuals per 1000 live births glob-
ally.1 2 CP is defined as ‘a group of permanent 
disorders of the development of movement 
and posture causing activity limitation[s] 
that are attributed to non- progressive distur-
bances that occurred in the developing fetal 
or infant brain’.3 Functional mobility in chil-
dren and young people with CP is usually clas-
sified according to the five- level gross motor 
function classification system (GMFCS), 
ranging from Level I, indicating maximal 
mobility with slight deficiencies in chal-
lenging activities, to Level V indicating full 
immobility and reliance on others.4 Approx-
imately two- thirds of the children are ambu-
lant within GMFCS I, II, III.5 Musculoskeletal 
deformities and resulting gait abnormalities 
are common and progressive during child-
hood, and lead to pathological and compen-
satory gait patterns.6
Many children with CP undergo lower limb 
orthopaedic surgery to address secondary 
musculoskeletal deformities and gait 
strengths and limitations of this study
 ► Rigorous core outcome set development meth-
ods that adhere to Core Outcome Measures in 
Effectiveness Trials guidelines.
 ► Different stakeholder inputs and engagement during 
the development of the protocol, in order to en-
sure outcomes that are important to patients, are 
identified.
 ► Support of several societies and charities that 
represent key stakeholders, which will facilitate 
participant recruitment during the Delphi process, 
dissemination and uptake of our core outcome sets.
 ► The Delphi exercise will be conducted using an on-
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abnormalities with the aim of improving or maintaining 
mobility.7Lower limb orthopaedic operations comprise 
a variety of soft tissue and bone procedures, including 
tendon/muscle lengthening or transfer and osteotomy 
or arthrodesis, often combined in the context of single- 
event multi- level surgery.8–10
Although many outcome measures for the evaluation 
of clinical trial results are in use, their application in 
the research context is largely inconsistent.7 The conse-
quences of research heterogeneity in outcome measures 
and outcome domains across studies limit the ability 
to compare findings among studies.11 12 Generic and 
clinician- administrated outcome measures such as clinical 
measurements of joint range of motion, spasticity, muscle 
strength and instrumented motion and gait analysis are 
employed in the majority of CP orthopaedic literature,7 
leaving the needs and expectations of both patient and 
caregivers unfulfilled.7 13 Furthermore, several reviews in 
CP lower limb orthopaedic surgery clinical trials have been 
suspected of selective outcome reporting bias.7 11 12 For 
example, McGinley and colleagues reported that adverse 
effects of single- event multi- level surgery weighed against 
its benefits are rarely addressed and only reported in a 
limited number of studies. Such inadequate reporting 
renders these studies less reliable and further reduces 
the ability to compare and combine studies through 
meta- analysis.12
The Core Outcome Measures in Effectiveness Trials 
(COMET) initiative brings together researchers inter-
ested in developing a standardised set of core outcomes 
in different health- related fields.14 A core outcome set 
(COS) is defined as ‘an agreed minimum set of outcomes 
that is recommended to be measured and reported in all 
clinical trials’.15 In recent years, limited consensus has 
been reached about what outcomes should be measured 
in CP. For example, there are five International Classifica-
tion of Functioning, Disability and Health (ICF) core sets 
for CP,16–20 one comprehensive and four brief sets. The 
ICF core sets for children and young people with CP offer 
service providers and stakeholders an age- appropriate 
framework to explore functioning and disability for 
assessment, treatment, evaluation and policy purposes 
in a global context. Specifically, the ICF core sets for CP 
standardise what should be measured and reported—
adopting the ICF biopsychosocial model. However, the 
ICF core sets do not include specific sets of interventions 
for this population.
Lower limb orthopaedic surgery is a common interven-
tion in the management of ambulatory children with CP. 
However, significant variation in the outcomes collected 
and reported remains a challenge. The post- surgical 
emotional and physical challenge that this treatment 
imposes on children and their families is significantly 
bigger than any other gait improvement intervention 
in this population. It is therefore of the highest impor-
tance to ensure that the surgical aims and the expected 
outcomes are of relevance to children and their families. 
Developing a COS representing all stakeholders for this 
specific intervention would represent the first step in this 
direction. Therefore, it is important to develop a COS that 
specifically addresses the needs of children and young 
people with CP undergoing lower limb orthopaedic 
surgery. A search of the COMET database and existing 
literature revealed that COS development has not been 
undertaken for the orthopaedic surgical management 
of lower limb problems in CP. Therefore, the aim of this 
study is to develop a COS for use in clinical trials involving 
lower limb orthopaedic surgery for ambulant children 
and young people with CP.
Conceptual framework
The COMET initiative emphasises the need for a compre-
hensive framework of healthcare when developing a 
COS.14 The WHO’s International Classification of Func-
tioning, Disability and Health for Children and Youth 
(ICF- CY) provides a useful framework that includes key 
aspects of a health condition and has been used exten-
sively in CP research.21–24 The ICF- CY has two parts: (1) 
functioning and disability and (2) contextual factors. 
Each part has two components; functioning and disability 
is subdivided into (a) body functions and structures and 
(b) activities and participation. Contextual factors are 
subdivided into environmental and personal factors.25 
Therefore, the ICF- CY framework taxonomy will be used 
as a basis of the development of COS.
scope
The scope of the COS will include four main areas based 
on the Core Outcome Set- STAndards for Development26: 
(1) population, (2) health condition, (3) intervention 
and (4) setting or context of use for which the COS is to 
be applied. Accordingly, the proposed COS will serve as 
an international standard that can be used to evaluate the 
overall success of lower limb orthopaedic surgery among 
ambulant children and young people with CP. It will 
comprise important outcomes (domains) and outcome 




The study design will follow the recommendations of the 
COMET initiative,14 with reporting adhering to the Core 
Outcome Set- STAndardised Protocol Items statement.27 
COS development will involve two main parts, first, devel-
oping the COS domains and second, developing the 
core outcome measures. A brief overview of our study 
design, including estimated time frames, is highlighted 
in figure 1.
stakeholder involvement
Stakeholders are defined as those who provide insight 
regarding outcomes of importance during the develop-
ment of the proposed COS. Box 1 lists potential stake-
holders, which include healthcare professionals and 
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Figure 1 Study design.
box 1 stakeholder involvement
Clinical academics (researchers)
 ► Healthcare scientists/researchers (expert in the fields of clinical 
research for cerebral palsy (CP), more specifically in the area of 
orthopaedics).
 ► Trialists and systematic reviewers.
healthcare professionals
 ► Have at least 2 years of clinical experience in CP.
 – Orthopaedic surgeons.
 – Paediatrics physiotherapists, occupational therapists.
 – Paediatrics nurses.
 – Orthotists.
 – Clinical scientists.
Children and young people, representative (family, carer)
 ► Diagnosed with CP.
 ► Age from 8 to 18 years old at the time of the surgery.
 ► Ambulant or within level I, II, III of gross motor function classification 
system.
 ► Have undergone or are being considered for lower limb orthopaedic 
surgical intervention.
 ► Family or carer of a child or young people with earlier criteria.
clinical academics (researchers), healthcare experts and 
children and young people with CP and their caregivers.
Establishing a steering committee
An international steering committee will be formed 
to guide the development of this COS. The steering 
committee will include 10–15 individuals ranging from 
experts in orthopaedic interventions, researchers, parents 
and patient representatives. Committee members will be 
provided input through face- to- face meetings and email 
communications.
Patient and public involvement
The development of this study protocol has been 
informed by discussions with a young adult with CP who 
has previously undergone lower limb orthopaedic surgery 
and with a parent representing approximately 40 fami-
lies of children with CP. Representatives confirmed the 
importance of the topic and partnered in the design of 
the study and the information material to support the 
interview and the Delphi methods. As a result, the study 
design was refined, tips were given on how to maximise 
the sample of participants (caregivers and patients) and 
feedback was given on the participant information sheet 
for both the interview and Delphi studies and the inter-
view topic guide questions.
IdEntIfyIng POtEntIAl OutCOME dOMAIns And OutCOME 
MEAsurEs
Phase 1: qualitative evidence synthesis
Research question and purpose
The review question for this study is: from the perspec-
tive of children with CP and their caregivers, what is the 
experience and expectation of outcomes after lower limb 
surgery?
The main purpose of the review is to (1) identify 
the aspect of health and outcomes that are considered 
important from the perspective of ambulatory children 
and young people with CP and their caregivers regarding 
to lower limb orthopaedic surgery and (2) explore how 
they experience lower limb orthopaedic surgery. A 
best- fit framework approach28 will be used and the data 
from primary qualitative studies will be coded against an 
existing model. The ICF- CY framework25 will be selected 
as a model ‘best- fit’ to extract the data from the included 
studies since the generated themes would represent a 
robust base of knowledge that form the first list of a future 
ICF- CY COS for lower limb orthopaedic surgery of ambu-
lant children and young people with CP. Data that do 
not fit the ICF- CY will be analysed inductively into addi-
tional themes through thematic analysis.29 Two reviewers 
will independently perform each stage of the review and 
resolve uncertainty through discussion. Review findings 
will be reported following enhancing transparency in 
reporting the synthesis of qualitative research statement 
guidelines to enhance transparency in reporting qualita-
tive evidence synthesis.30 The review protocol is available 
online via the PROSPERO database.
Search strategy
A systematic search will be conducted using four databases, 
Medical Literature Analysis and Retrival System Online 
(MEDLINE), Excerpta Medica Database (EMBASE), 
PsychINFO and Cumulative Index to Nursing and Allied 
Health Literature (CINAHL) with search terms and 
free- text terms combining four components: (1) CP; (2) 
perspective and experience; (3) orthopaedics, muscu-
loskeletal and (4) qualitative research methodologies 
(online supplementary file 1). The search will include 
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Table 1 ICF linking rules
Number Rule
1 Acquire good knowledge of the conceptual and taxonomical fundamentals of the ICF, as well as of the chapters, 
domains and categories of the detailed classification, including definitions before starting to link meaningful 
concepts to the ICF categories
2 Identify the main concept(s) most relevant to be linked to the ICF
3 Identify any additional concepts contained in the piece of information in addition to the main concept(s) already 
identified in the previous step
4 Identify and document the perspective taken on within a certain piece of information when linking it to the ICF
5 Identify and document the categorisation of the response options
6 Link all meaningful concepts, the most relevant and additional ones, to the most precise ICF category
7 Use ‘other specified’ or ‘unspecified’ ICF categories as appropriate
8 If the information provided by the meaningful concept is not sufficient for making a decision about the most precise 
ICF category, assign the concept to nd (not definable)
9 If the meaningful concept is not contained in the ICF, but is clearly a personal factor as defined in the ICF, assign the 
meaningful concept to pf (personal factors)
10 If the meaningful concept is not contained in the ICF, assign this meaningful concept to nc (not covered)
ICF, International Classification of Functioning, Disability and Health.
relevant studies from inception to January 2018. In addi-
tion, the citation and the reference lists of all included 
studies will be checked through Web of Science citation 
search to identify any additional potentially relevant 
studies.
Study selection and eligibility criteria
Potential studies will be exported into the EndNote 
X8.2 reference manager and duplicates will be removed. 
Studies will be put through a two- stage screening process. 
Titles and abstracts of studies identified by the search 
will be assessed against the inclusion criteria first; then, 
selected studies will be read in full to determine inclu-
sion. Studies will be eligible if they meet the following 
inclusion criteria: (1) the study population consisted of 
individuals diagnosed with CP and/or their parent or 
primary caregiver; (2) the study participants were ambu-
latory or within level I, II, III of the GMFCS; (3) the study 
explored the experience of children and young people 
with CP and their family following lower limb surgery 
and their expectations of the surgery outcomes; (4) the 
study employed a qualitative design; (5) in the case of 
mixed- method studies, data from the quantitative and 
qualitative approaches were analysed and reported sepa-
rately; (6) full article was published in English. Opin-
ions, editorials and articles containing only quantitative 
data will be excluded. Studies with samples representing 
several types of disabilities will be excluded if the authors 
did not define findings by type or specify which findings 
were linked to individuals with CP. In addition, studies 
with only an abstract and those published as poster will be 
excluded as it would not be possible to adequately assess 
their methodological quality.
Quality appraisal
Identified studies will be assessed by the critical appraisal 
skills programme tool.31 Studies will also be assessed 
using the Dixon- Woods and colleagues categorisation 
method,32which consists of a global appraisal of whether 
the study was a key or satisfactory paper, as opposed to a 
paper that was irrelevant to the synthesis or methodolog-
ically fatally flawed.
Data extraction
A template will be created for extracting data from the 
identified studies. The major elements comprised key 
research aims; details of the research context; partici-
pants; data collection and analysis methods.
Synthesis
In order to map data onto precise ICF- CY codes, the ICF 
linking rule will be used (table 1).33 Each line of text will 
be coded according to its meaning and will be linked to 
the most precise ICF- CY code. If the content of a code 
is not explicitly named in the ICF- CY category, the ‘not 
defined’ and ‘not covered’ category will be applied. Data 
that do not fit the ICF- CY will be analysed thematically.29
The data will be linked to the ICF- CY separately by 
two reviewers. A third independent reviewer with exper-
tise in the concepts and taxonomy of the ICF- CY will 
be consulted to resolve disagreements between the two 
reviewers concerning the selected categories. The process 
will be discussed and refined by three reviewers to develop 
a final list of relevant themes.
Phase 2: scoping review
Research question and purpose
This review aimed to answer these questions: (1) what 
outcomes are reported in the medical literature after 
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lower limb orthopaedic surgery for ambulant children 
with CP? And (2) what outcome measures are used in this 
field?
The purpose of this scoping review is to identify rele-
vant outcome domains and outcome measures used in 
clinical trials of lower limb orthopaedic surgery for CP. 
Although previous scoping reviews for studies published 
between 1990 and 2015 were identified,7 34 updating the 
review was important to ensure that recently published 
outcome domains and outcome measures were identified. 
This was important particularly because, in recent years, 
researchers and healthcare professionals have become 
more aware of patient priorities and have acknowledged 
the value of patient- reported outcomes. These outcomes 
and outcome measures will underpin the consensus on 
selecting outcomes of important and outcome measures. 
According to the Cochrane Review recommendation, a 
review update should be re- conducted using the same 
methods as the original review35; therefore, this review 
was in line with the methodology of the original scoping 
review.7 The review will be developed in accordance with 
the Preferred Reporting Items for Systematic Reviews and 
Meta- Analyses Protocol guidelines. Two reviewers will 
independently undertake each stage of the review. The 
research team will resolve any uncertainty and provide 
consensus after each stage through discussion. The 
review will be reported following the Preferred Reporting 
Items for Systematic review and Meta- Analysis for Scoping 
Reviews (PRISMA- ScR) checklist.36
Search strategy
A systematic search of five databases (MEDLINE, PubMed, 
EMBASE, CINAHL and the Cochrane Controlled- Trials 
Registry) will be performed. Search terms including 
‘cerebral palsy’ AND ‘surgical procedures’ OR ‘surgery’ 
OR ‘operative’ will be used. Reference lists of all studies 
identified will be hand searched to identify any additional 
potentially relevant studies. All studies published between 
January 2016 and June 2019 will be included.
Study selection
Potential studies will be exported into the reference 
manager, EndNote X8.2, and duplicated studies will 
be removed. Studies will then go through a two- stage 
screening process. First, the titles and abstracts will be 
assessed against the inclusion criteria. Second, a full- text 
screening will be undertaken of all studies that were iden-
tified in the first step.
Eligibility criteria
Studies will be eligible if they meet the following inclusion 
criteria: (1) ambulatory children and young people diag-
nosed with CP; (2) participants are aged between 0 and 20 
years old; (3) have had lower limb orthopaedic surgery; 
(4) studies reported at least one outcome measure; (5) 
each outcome measure must have at least one published 
paper reporting its psychometric properties; (6) the full 
article was published in English. Purely observational 
investigations and qualitative studies, grey literature, 
studies involving only adults, those with patients receiving 
alternative therapy or pharmacologic interventions, and 
papers that reported surgery performed only for hip 
dysplasia will be excluded.
Data extraction
A pre- designed standardised data- extraction form will 
be used to extract the main characteristics of identified 
studies. Information extracted will include author, year of 
publication, aim/purpose, study population and sample 
size, methodology, intervention type, outcome domains 
and outcome measures used.
Analysis
Content analysis will be used to identify the breadth of 
content of the identified outcome domains and measures, 
which will then be mapped to the ICF- CY domains. 
After mapping, each outcome domain and measure will 
be analysed descriptively. Descriptive analyses will be 
conducted to determine the frequency and proportion of 
each outcome reported and of instruments used to assess 
identified outcome domains.
Phase 3: qualitative study
Research question and purpose
The following question will guide the study: what outcome 
domains are considered important by ambulant children 
and young people with CP, their caregivers and health 
professionals after lower limb orthopaedic surgery? Chil-
dren and young people with CP and their families may 
prioritise different outcomes post- surgery. Thus, the aim 
of the qualitative study is to identify important outcome 
domains from each stakeholders’ group.
Study sample
A purposive sampling strategy37 will be used to include 
a range of stakeholders: (1) children and young people 
with CP and their representatives (family, carer); (2) 
health professionals who have at least 2 years of clinical 
experience in CP (box 1). The study will only include 
English speakers who have the capacity to give informed 
consent for themselves or their children (under 16 years 
old). Data saturation will be defined as a point at which 
data from three consecutive interviews do not contribute 
to additional themes. It is likely that a sample of 20 partic-
ipants will allow data saturation.38
Recruitment
Participants will be recruited from the paediatric ortho-
paedic clinic at the Nuffield Orthopaedic Centre in 
Oxford. Information for potential participants will be 
provided verbally by the usual care team and a participant 
information leaflet will be used. Healthcare professionals 
and clinical academics (researchers) will be invited 
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box 2 selection of delphi panel member
Clinical academics (researchers)
 ► Personalised recruitment emails.
 – Researchers of primary studies identified from the scoping 
review.
 – Healthcare scientists/researchers (expert in the fields of clinical 
research for cerebral palsy (CP), more specifically in the area of 
orthopaedics).
 – Trialists and systematic reviewers.
 ► Snowball sampling.
healthcare professionals
 ► Personalised recruitment emails.
 – National and international societies and associations focusing on 
paediatric CP.
 ► Social media of these societies, associations and organisations.
 ► Snowball sampling.
Children and young people, representative (family, carer)
 ► Personalised recruitment emails.
 – National and international charities of CP, disabilities, families.
 – Patients/families attending clinics at the Nuffield Orthopaedic 
Centre, Oxford.
 ► Social media of the earlier charities.
Consent
Written informed consent will be obtained from potential 
participants prior to conducting the interviews. Individ-
uals who do not have capacity to give informed consent 
will not be included in the study. It will be stressed that 
participants are under no obligation to take part and 
they are free to withdraw at any time without affecting 
their medical care (CP children and their representa-
tives) or legal rights (for healthcare professionals and 
researchers).
Data collection
Semi- structured interviews will take place at a time and 
place convenient to the participant. This might be in a 
clinic room at the hospital or at the participant’s home. 
Young adults (16–18 years old) will be given the option 
of an interview separately from their caregivers. The 
following demographic information will be collected: 
child age, identity, operation history, year of health profes-
sional’s experience. Interviews will be semi- structured 
and include several open- ended questions to encourage 
participants’ thoughts and opinions, guided by a topic 
guide to ensure key areas are covered. The interview topic 
guide will be formed and shaped by the findings of phases 
1 and 2. For example, participants will be asked to reflect 
on the identified outcome domains from the reviews. 
Child- friendly techniques through using a talking mat 
(https://www. talkingmats. com/) will be available for chil-
dren aged 8–15 years old to enhance children’s participa-
tion and interest in answering the questions. Talking mat 
is an interactive resource that designed picture symbols to 
facilitate communication and provide structured frame-
work for open questions. To facilitate children’s partici-
pation and engagement, a play specialist will be available 
during the children interviews.
Data analysis
Interviews will be audio- recorded and transcribed. Partic-
ipant will be identified only by a code (participant ID 
number) on trial documents and in any electronic data-
base to maintain confidentiality.
Data will be analysed through content analysis. Data 
will be coded, indexed and charted to identify themes or 
patterns of key points and priorities.39 The list of priori-
tised outcomes generated by the analysis will be system-
atically classified using an international ICF framework 
linking process outlined by Cieza and colleagues.33 If 
participants identify domains that are outside the ICF cate-
gories, these will be documented, analysed and reported. 
The resulting ICF codes will be analysed in terms of their 
representation across ICF- CY components and between 
stakeholder groups.
Potential outcome domains and outcome measures
A list of potential outcomes domains derived from the 
qualitative evidence synthesis (phase 1), scoping review 
(phase 2) and semi- structured interviews (phase 3) will 
be collected and assessed by the COS steering committee. 
The steering committee will revise the phrasing of the 
potential domains to confirm clarity, relevance and suit-
ability prior to the Delphi process (phase 4).
dEtErMInIng COrE OutCOME sEts
Phase 4: delphi process
Research question and purpose
The study aims to answer the following question: which 
outcomes do children and young people with CP, care-
givers and healthcare professionals think should be 
included in a COS for lower limb orthopaedic surgery? 
The aim of the Delphi survey40 is to gain consensus on 
important lower limb orthopaedic surgery outcome 
domains from the perspective of stakeholders.
Selection of panel members and sample size
The eligibility criteria shown in Box 1 will be used as 
a guide in the selection of the Delphi panel members. 
Potential Delphi panel members will be invited to a two- 
stage Delphi survey. The aim is to maintain a minimum 
of 40 participants representing each stakeholder group 
throughout the Delphi rounds, including (1) children 
and young people and their caregivers, and (2) health 
professionals. Balanced representation of multiple view-
points, and expertise will be considered.41 Based on an 
estimated attrition of 30% across rounds,14 the initial 
target recruitment will be approximately 100 participants.
Recruitment
Different strategies will be followed to identify the poten-
tial panel, as shown in box 2. Clinical academics and 
healthcare professionals will be invited through profes-
sional societies. Specific invitations to authors of relevant 
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references identified through the qualitative evidence 
synthesis and scoping review will be also targeted. Snow-
balling techniques will be used to ensure a representative 
sample of international researchers and clinicians are 
invited. Children and family recruitment will be initiated 
through the clinical care team at Nuffield Orthopaedic 
Centre (Oxford, UK) and will expand nationally and 
internationally to include patient and parent organisa-
tions and charities.
Delphi survey
Adapted participant information leaflets developed 
from the COMET initiative will be used to outline the 
rationale for the development of the proposed COS and 
describe the requirements for taking part in the Delphi. 
A child- friendly animation will be developed to explain 
the rationale of the study and promote children’s under-
standing of the purpose of the COS (online supplemen-
tary file 2). The Jisc online survey tool will be used. The 
Delphi survey will be pilot tested by the members of the 
steering committee to assess face validity, understanding 
and acceptability. Demographic information will be 
collected at the start of the Delphi survey to describe 
the study sample, and to provide each respondent with 
a unique identifier enabling personalised reminders 
for completion of subsequent rounds. This information 
will include the stakeholder group that the participant 
belongs to, the age group, years of experience, and 
position.
Participants will be asked to score each outcome in the 
Delphi using a GRADE scale, which ranges from 1 to 9 
(1 to 3=not important, 4 to 6=important but not critical 
and 7 to 9=critical for inclusion).42 The proposed scoring 
system was selected to facilitate maximum discrimination 
between items. There will be free- text fields to allow 
the participants to give a reason for their decision and/
or any additional outcomes that they consider to be 
important. Items scored between 7 and 9 (critical impor-
tance) by ≥75% will be directly moved to the following 
stage (ie, consensus meeting) for discussion. Items 
scored between 1 and 3 (not important) by ≥25% will be 
excluded from the round 2 of the Delphi survey. Only 
items scored between 4 and 6 (important but not crit-
ical) will be carried out in round 2 of the Delphi survey. 
Additional outcomes from the free- text field will be 
reviewed by the research team and where appropriate 
carried forward to round 2. During round 2 of the 
Delphi survey, participants will be asked to re- score the 
importance of each outcome that were scored between 
4–6. A consensus process will be carried out similar to 
that in round 1. A report with findings including all 
items results and consensus category will be presented 
in the consensus meeting. Each round will be open to 
the panel for 4 weeks and reminder emails will be sent 
at 2 week intervals in order to maximise follow- up rates. 
Only the research team will have access to the complete 
list of those taking part in the Delphi survey.
Analysis
Descriptive statistics will be undertaken using Statis-
tical Package for the Social Sciences (SPSS) software to 
summarise the distribution of scores and to calculate 
the median and IQR for each Delphi survey item. The 
denominator for each Delphi survey item will be the 
number of participants completing that item, rather 
than the number of participants completing the Delphi 
survey overall (ie, a participant may choose not to score a 
particular Delphi item for whatever reason). Survey data 
will be analysed separately for each stakeholder group. 
Outcomes from both rounds will be analysed descrip-
tively; the number of participants rating each outcome 
from rounds 1 and 2 will be calculated.
Phase 5: consensus meeting
Recruitment
A consensus meeting will be hosted for the purpose of 
finalising the COS. The meeting will include approx-
imately 20 panel members. Representatives from all 
stakeholder groups, representing as much geographical, 
ethnic, demographic and cultural diversity as possible (as 
recommended by COMET) will be invited at this stage. 
Ten of those participants will be randomly selected from 
the Delphi survey participants and the study steering 
group. Face- to- face and remote access to the meeting will 
be available.
Final decisions
At the meeting, Delphi survey results will serve as the basis 
for the discussion and development of the final COS to be 
agreed across stakeholder groups. Across all stakeholder 
groups, any outcome categorised as ‘consensus in’ will 
be proposed to be included in the final COS, while any 
outcome categorised as ‘consensus out’ will be excluded. 
The panel members will electronically vote to accept 
this proposal or suggest outcomes that warrant further 
discussion.
Outcomes that are differently categorised by different 
stakeholder groups and those categorised as ‘no- con-
sensus’ will be discussed individually. A second round 
of voting will be used to agree the final COS. A second 
meeting will be arranged in the event of no agreement 
on the final COS at the end of the first meeting. Based on 
COMET recommendations, the final COS is expected to 
include five to ten outcomes.14
Phase 6: selection of outcome measure
After the development of a COS, it is recommended to 
identify a set of measurements, the ‘outcome measures’ 
that would be used to evaluate the selected outcomes.43 In 
order to establish a core outcome measures set, a four- step 
process will be followed: (1) conceptual considerations 
(scope); (2) identifying existing outcome measures; (3) 
quality assessment of the identified outcome measures 
and (4) generic recommendations for the selection of 
outcome measures for a COS.
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The conceptual considerations of the proposed core 
outcome measures set will be associated with the study 
scope. Accordingly, all available outcome measures used 
in clinical research following lower limb orthopaedic 
surgery in ambulant CP will be considered for the core 
set. An international perspective on the subject will be 
captured by involving stakeholders from the study’s 
international steering committee and consensus panel 
members.
Previous reviews on this field7 34 alongside the scoping 
review (phase 2) will be used as a starting point to identify 
currently used outcome measures. The quality assessment 
of each outcome measure identified will be determined 
by the available systematic reviews using the consensus- 
based standards for selection of health measurement 
instruments (COSMIN). This will assess the psychometric 
properties of outcome measures that have been used in 
CP clinical studies. For example, two recent systematic 
reviews using a modified COSMIN method to assess gait- 
related outcome measures in CP will be employed to 
choose suitable, high- quality outcome measures.44 45
A consensus meeting with a panel of health professionals 
will subsequently be organised to establish appropriate 
outcome measures for each outcome domain identified 
during the COS development. Members will be asked to 
recommend one high- quality outcome measure per core 
outcome domain. If no adequate outcome measures exist 
for a specific core outcome, this will be acknowledged, 
and recommendation will be made for future develop-
ment of an adequate high- quality outcome measure.
EthICs And dIssEMInAtIOn
Informed consent will be obtained from all participants 
taking part in the interview and Delphi process. All proce-
dures will be conducted according to the Declaration of 
Helsinki.
Support of societies, associations and charities that 
represent health professionals, families of children and 
young people with CP will facilitate dissemination of the 
COS and subsequent uptake, for example, the ‘British 
Society for Children Orthopaedic Surgery’, ‘Step charity’ 
and ‘Action Cerebral Palsy’. A one- page summary will 
be provided to the clinicians and researchers and a lay 
language summary will be available for the patients and 
their caregivers to the relevant societies. The findings will 
be submitted for publication in peer- reviewed and open 
access journals and will be presented at national and 
international conferences on CP. Journals and funding 
bodies will be approached to promote awareness of the 
COS results.
dIsCussIOn
To our knowledge, this is the first study on the develop-
ment of a COS for lower limb orthopaedic surgery in 
ambulant children with CP. This study employed a well- 
established and widely used method developed by the 
COMET Initiative. Involving patients in COS develop-
ment has become common practice to ensure the rele-
vance of the proposed COS to all stakeholders. In this 
protocol, children and families will be directly engaged 
with the COS development through participation in the 
steering committee, the interviews, the Delphi process 
and the consensus meeting.
This study includes a comprehensive search for poten-
tially relevant outcomes through qualitative evidence 
synthesis, a scoping review and interviews with stake-
holders’ groups. This process will be conducted by at least 
two independent researchers ensuring identification of 
all potential outcomes. This will provide a comprehensive 
list of all pertinent outcomes for the Delphi survey.
As the comprehensive search for outcomes focuses 
on the English literature and on interviews with English 
speaking stakeholders, any outcomes available in the 
non- English literature may be omitted. Free- text fields 
will be included in the Delphi survey to allow participants 
to suggest any additional outcomes that they consider 
important. The potential imbalance between national 
and international participants may represent a limitation 
of the study. Although the proposed COS development 
will aim to reach international consensus, it is possible 
that most participants will be recruited from the UK, 
which may affect the wider generalisability of the COS 
findings.
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